These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 18212328)

  • 41. Role of arylamine N-acetyltransferase 1 and 2 (NAT1 and NAT2) genotypes in susceptibility to oral/pharyngeal and laryngeal cancers.
    Jourenkova-Mironova N; Wikman H; Bouchardy C; Mitrunen K; Dayer P; Benhamou S; Hirvonen A
    Pharmacogenetics; 1999 Aug; 9(4):533-7. PubMed ID: 10780274
    [No Abstract]   [Full Text] [Related]  

  • 42. Quantitative tissue and gene-specific differences and developmental changes in Nat1, Nat2, and Nat3 mRNA expression in the rat.
    Barker DF; Walraven JM; Ristagno EH; Doll MA; States JC; Hein DW
    Drug Metab Dispos; 2008 Dec; 36(12):2445-51. PubMed ID: 18799802
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Association between polymorphisms at N-acetyltransferase 1 (NAT1) & risk of oral leukoplakia & cancer.
    Majumder M; Ghosh S; Roy B
    Indian J Med Res; 2012 Oct; 136(4):605-13. PubMed ID: 23168701
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cloning, sequencing, and recombinant expression of NAT1, NAT2, and NAT3 derived from the C3H/HeJ (rapid) and A/HeJ (slow) acetylator inbred mouse: functional characterization of the activation and deactivation of aromatic amine carcinogens.
    Fretland AJ; Doll MA; Gray K; Feng Y; Hein DW
    Toxicol Appl Pharmacol; 1997 Feb; 142(2):360-6. PubMed ID: 9070359
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Retrospective analysis of estrogen receptor 1 and N‑acetyltransferase gene expression in normal breast tissue, primary breast tumors, and established breast cancer cell lines.
    Carlisle SM; Hein DW
    Int J Oncol; 2018 Aug; 53(2):694-702. PubMed ID: 29901116
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Deciphering the ancient and complex evolutionary history of human arylamine N-acetyltransferase genes.
    Patin E; Barreiro LB; Sabeti PC; Austerlitz F; Luca F; Sajantila A; Behar DM; Semino O; Sakuntabhai A; Guiso N; Gicquel B; McElreavey K; Harding RM; Heyer E; Quintana-Murci L
    Am J Hum Genet; 2006 Mar; 78(3):423-36. PubMed ID: 16416399
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Arylamine N-acetyltransferases: characterization of the substrate specificities and molecular interactions of environmental arylamines with human NAT1 and NAT2.
    Liu L; Von Vett A; Zhang N; Walters KJ; Wagner CR; Hanna PE
    Chem Res Toxicol; 2007 Sep; 20(9):1300-8. PubMed ID: 17672512
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Relevance of N-acetyltransferase 1 and 2 (NAT1, NAT2) genetic polymorphisms in non-small cell lung cancer susceptibility.
    Wikman H; Thiel S; Jäger B; Schmezer P; Spiegelhalder B; Edler L; Dienemann H; Kayser K; Schulz V; Drings P; Bartsch H; Risch A
    Pharmacogenetics; 2001 Mar; 11(2):157-68. PubMed ID: 11266080
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A meta-analysis of the NAT1 and NAT2 polymorphisms and prostate cancer: a huge review.
    Gong C; Hu X; Gao Y; Cao Y; Gao F; Mo Z
    Med Oncol; 2011 Mar; 28(1):365-76. PubMed ID: 20099048
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Characterization of N-acetyltransferase 1 activity in human keratinocytes and modulation by para-phenylenediamine.
    Bonifas J; Scheitza S; Clemens J; Blömeke B
    J Pharmacol Exp Ther; 2010 Jul; 334(1):318-26. PubMed ID: 20406859
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Human acetyltransferase polymorphisms.
    Grant DM; Hughes NC; Janezic SA; Goodfellow GH; Chen HJ; Gaedigk A; Yu VL; Grewal R
    Mutat Res; 1997 May; 376(1-2):61-70. PubMed ID: 9202739
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Genetic variants of N-acetyltransferases 1 and 2 (NAT1 and NAT2) in cynomolgus and rhesus macaques.
    Uno Y; Murayama N; Yamazaki H
    Biochem Pharmacol; 2020 Jul; 177():113996. PubMed ID: 32339492
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characterization of genetic variation and natural selection at the arylamine N-acetyltransferase genes in global human populations.
    Mortensen HM; Froment A; Lema G; Bodo JM; Ibrahim M; Nyambo TB; Omar SA; Tishkoff SA
    Pharmacogenomics; 2011 Nov; 12(11):1545-58. PubMed ID: 21995608
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Meat intake and risk of non-Hodgkin lymphoma.
    Aschebrook-Kilfoy B; Ollberding NJ; Kolar C; Lawson TA; Smith SM; Weisenburger DD; Chiu BC
    Cancer Causes Control; 2012 Oct; 23(10):1681-92. PubMed ID: 22890783
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Are polymorphisms of N-acetyltransferase genes susceptible to primary liver cancer in Luoyang, China?
    Zhang XF; Bian JC; Zhang XY; Zhang ZM; Jiang F; Wang QM; Wang QJ; Cao YY; Tang BM
    World J Gastroenterol; 2005 Mar; 11(10):1457-62. PubMed ID: 15770721
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Arylamine N-acetyltransferase 1 (NAT1) and 2 (NAT2) genes and risk of urothelial transitional cell carcinoma among Japanese.
    Katoh T; Inatomi H; Yang M; Kawamoto T; Matsumoto T; Bell DA
    Pharmacogenetics; 1999 Jun; 9(3):401-4. PubMed ID: 10471074
    [No Abstract]   [Full Text] [Related]  

  • 57. Prospective study of NAT1 and NAT2 polymorphisms, tobacco smoking and meat consumption and risk of colorectal cancer.
    Sørensen M; Autrup H; Olsen A; Tjønneland A; Overvad K; Raaschou-Nielsen O
    Cancer Lett; 2008 Aug; 266(2):186-93. PubMed ID: 18372103
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Isoform-selective inactivation of human arylamine N-acetyltransferases by reactive metabolites of carcinogenic arylamines.
    Liu L; Wagner CR; Hanna PE
    Chem Res Toxicol; 2009 Dec; 22(12):1962-74. PubMed ID: 19842618
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cigarette smoking, N-acetyltransferase genes and the risk of advanced colorectal adenoma.
    Moslehi R; Chatterjee N; Church TR; Chen J; Yeager M; Weissfeld J; Hein DW; Hayes RB
    Pharmacogenomics; 2006 Sep; 7(6):819-29. PubMed ID: 16981843
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Phenotype of the most common "slow acetylator" arylamine N-acetyltransferase 1 genetic variant (NAT1*14B) is substrate-dependent.
    Millner LM; Doll MA; Cai J; States JC; Hein DW
    Drug Metab Dispos; 2012 Jan; 40(1):198-204. PubMed ID: 22010219
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.